Case studies
Our success is defined by our culture and shared ambition to create a positive impact, here you can find our caser studies which really showcase the best of our Commitment and our Purpose.
Customer award for carbon reduction
We’ve been working in partnership with Syngenta to deliver innovative and sustainable ingredients in a way that meets their commercial and sustainability goals.
Focusing on D&I in Asia
Colleagues in Asia have been leading a programme of raising awareness, building an inclusive culture, and driving inclusivity in recruitment.
Human Performance programme
Our behavioural safety improvement programmes were standardised into a Group-wide Behavioural Safety Observation programme, implemented across all manufacturing sites since 2015.
Customer driven
We are listening more closely to our customers than ever before; understanding the things that are of most importance to our customers and how we are performing against them.
Croda supports Pfizer-BioNTech COVID-19 vaccine
Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs...
Improving the customer experience in China
Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.
Reforestation
Revitalising ecosystems, improving biodiversity and creating social and economic benefits for local communities.
Investing in mRNA and gene therapy
As the core of our lipid systems capability within the Health Care business, Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific...
Responsible business
/Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image
1.5°C science-based target validation
In July 2021 we became only the third major chemical company globally to have a 1.5ºC science-based target validated.
Investing in organic expansion in Agriculture
Atlox 4913TM is valued by customers for creating stable dispersions in complex crop formulations, ensuring consistent distribution of actives and preventing formulation breakdown.
Supplying delivery systems to help prevent cardiovascular disease
Nucleic acid-based therapies are the next big blockbuster drug class opening up exciting applications such as gene editing, where a patient’s genetic material can be modified to correct a disorder.
Leveraging expertise in UV filters for Asian markets
There are over three million cases of skin cancer globally each year, responsible for tens of thousands of deaths. Our range of sunscreens meets a clear need and is an important pillar of our...
Supporting the next generation of therapeutic vaccines
Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.
Leveraging Group-wide capabilities to accelerate the development of natural active ingredients
The move in cosmetics towards replacing synthetic ingredients with sustainable alternatives is increasing demand for naturally sourced actives.
Sustainability without compromise ChromaPur
Small, manufactured plastic particles, known as microbeads, are used in a wide range of cosmetic and personal care products, with research suggesting that 87% of products from the ten best-selling...
Net zero roadmap for UK manufacturing site
We became one of the first UK manufacturing sites to develop a 2050 net zero roadmap as part of the UK Government’s Department for Business, Energy and Industrial Strategy ‘Industry of the Future’...
Sustainable ways of working in R&D
We are focused on aligning the work of our global R&D teams with the United Nations Sustainable Development Goals (SDGs).
New frontiers in fragrance and flavours
Croda acquired international fragrances and flavours company Iberchem in 2020, the largest acquisition in our history and a major move into a market strongly aligned with our business.